Delayed emesis following anticancer chemotherapy Journal Article


Authors: Kris, M. G.; Roila, F.; De Mulder, P. H. M.; Marty, M.
Article Title: Delayed emesis following anticancer chemotherapy
Abstract: Delayed emesis is a distinct syndrome where vomiting begins or persists 24 or more hours after chemotherapy. It is more likely to occur when the stimulus for emesis is strong and/or acute vomiting is poorly controlled. The pathophysiology appears different than that which causes acute emesis. The literature reporting clinical trials to prevent delayed nausea and vomiting are presented. The best ways of preventing delayed emesis following anticancer chemotherapy are discussed.
Keywords: cancer chemotherapy; treatment outcome; review; cisplatin; antineoplastic agents; pathophysiology; chemotherapy; antineoplastic agent; neoplasms; palliative care; nausea; vomiting; antineoplastic combined chemotherapy protocols; cyclophosphamide; time factors; antiemetics; clinical trials; delayed emesis; antiemetic activity; cancer; humans; human; priority journal; antiemetic therapy
Journal Title: Supportive Care in Cancer
Volume: 6
Issue: 3
ISSN: 0941-4355
Publisher: Springer Verlag  
Date Published: 1998-04-01
Start Page: 228
End Page: 232
Language: English
DOI: 10.1007/s005200050158
PUBMED: 9629874
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 12 December 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Kris
    869 Kris